Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 8—August 2023
Research Letter

Fatal Meningitis from Shiga Toxin–Producing Escherichia coli in 2 Full-Term Neonates, France

Tables
Article Metrics
Author affiliations: Robert Debré University Hospital Assistance Publique-Hôpitaux de Paris, Paris, France (G. Geslain, A. Cointe, P. Bidet, C. Courroux, P. Mariani, S. Bonacorsi); Université Paris Cité INSERM, Paris (G. Geslain, A. Cointe, P. Bidet, S. Bonacorsi); Mayotte Hospital, Mamoudzou, Mayotte Island, France (S. Abasse)

Cite This Article

Abstract

We report fatal meningitis in 2 neonates in France caused by Shiga toxin 1–producing Escherichia coli. Virulence factors capsular K1 antigen and salmochelin were present in both strains, potentially representing a new hybrid pathotype. Clinicians should remain aware of emerging pathotypes and design therapeutic strategies for neonatal E. coli infections.

Escherichia coli can acquire virulence factors associated with increased pathogenicity, causing intestinal or extraintestinal infections. Shiga toxin (Stx)–producing E. coli (STEC) cause intestinal infections and hemolytic uremic syndrome (HUS). E. coli virulence factors K1 antigen and salmochelin are associated with neonatal E. coli meningitis (1). Hybrid pathotypes have been described, such as Stx-producing O80:H2, which causes HUS and bacteremia because of extraintestinal virulence–associated plasmid pS88 (2). We report 2 cases of full-term neonates who died of meningitis caused by STEC serotypes O117:H7 and O156:H7.

Patient 1, an 8-day-old full-term boy born in the Paris, France, area, was seen at the emergency department because of a 48-hour history of abdominal pain and rectorrhagia without fever and drowsiness since that morning. Septic shock with colitis developed rapidly, requiring admission to the pediatric intensive care unit (PICU). Hemolysis was not observed, and initial acute kidney failure resolved promptly. Blood culture results were positive for E. coli K1, urine culture results were negative, and 3 stool cultures yielded STEC. Cerebral magnetic resonance imaging on PICU day 7 showed severe diffuse lesions indicating meningoencephalitis and subdural empyema. Cerebrospinal fluid (CSF) obtained by lumbar puncture 2 days later contained 2,270 leukocytes/mm3, showed negative Gram stain and culture, and was PCR-positive for K1 and β-glucuronidase genes, indicating E. coli meningitis. Prompted by clinical and laboratory features potentially associated with HUS, PCR on blood and CSF DNA were performed and identified stx1. The patient died on day 28.

Patient 2, a full-term boy born in an overseas department of France, was transferred to a PICU at 4 days of age because of fever, drowsiness, and failure to feed. Septic shock without colitis developed rapidly, without hemolysis or initial thrombocytopenia. On PICU day 4, blood culture results were positive and urine culture results negative for E. coli; CSF contained 900 leukocytes/mm3 and showed E. coli growth in culture; Stx was not initially evaluated. The patient died on PICU day 9.

Whole-genome sequencing of blood and stool isolates (patient 1) and CSF isolate (patient 2) indicated the E. coli strains belonged to sequence type (ST)504 and phylogroup B2; serotypes were O117:H7 for patient 1 and O156:H7 for patient 2. Both strains harbored the gene encoding Stx1a protein but not eae (intimin) or ehxA (enterohemolysin) genes (3,4). Genetic determinants for extraintestinal virulence factors K1 capsular antigen, yersiniabactin, and salmochelin were present in both strains and the aerobactin operon in the O117:H7 strain. Screening for confirmed or putative virulence factors as previously described (5) (Table) showed neither strain harbored an pS88-like plasmid (6).

Both strains differed substantially from E. coli K1 strains usually reported as causes of meningitis. K1 strains mainly belong to the ST95 complex (7) and most common serogroups are O18, O1, O7, O83, and O45 S88 (6,8). STEC O117:H7 ST504 strains were described in 2005 in 20 adults with persistent traveler’s diarrhea (3). Those strains and STEC strains described in another study of traveler’s diarrhea were atypical because they did not express lysine decarboxylase, β-galactosidase, intimin, or enterohemolysin (4). No invasive infections were reported before the 2 cases we describe, although some strains expressed extraintestinal virulence factors. However, because PCR for Stx is not routinely performed on neonatal invasive E. coli strains, STEC O117:H7 might be underestimated. Whole-genome sequencing of neonatal E. coli meningitis strains would help determine the role of STEC in fatal neonatal meningitis. In our patients, simultaneous presence of K1 antigen and salmochelin might explain isolate invasiveness (1). Moreover, STEC O156:H7 harbored the invasin IbeA, which promotes blood–brain barrier translocation.

When we analyzed the EnteroBase database (9) in late 2022, we identified only 4 O156:H7 and 39 O117:H7 strains distributed among 4 STs (ST504, n = 17; ST5292, n = 18; ST6880, n = 3; and ST9996, n = 1), all belonging to the ST504 complex. BLAST (https://blast.ncbi.nlm.nih.gov) analysis of STEC O117:H7 ST504 complex sequences from Enterobase consistently identified extraintestinal virulence factors yersinibactin and aerobactin (5); salmochelin (12 of 39 sequences) and K1 antigen (20 of 39 sequences) were inconsistently present. Since routine STEC sequencing began in 2017 in France, 3 other STEC O117:H7 ST504 complex strains have been identified (2 from patients with nonhemorrhagic diarrhea and 1 from an asymptomatic carrier).

Neither neonate described in this report had typical HUS, possibly because the E. coli strains lacked genes encoding Stx2, intimin, and enterohemolysin. However, Stx might have promoted intestinal translocation of the bacteria. Furthermore, antimicrobial drug therapy might have induced intracerebral Stx production, thereby contributing to fatal outcomes (10).

ST504 complex STEC strains exhibit only moderate intestinal virulence. However, we show that those strains can translocate into blood and CSF in neonates, especially if they produce K1 antigen and salmochelin. ST504-complex STEC expressing K1 antigen and salmochelin might be new hybrid pathotypes in neonates, even for those born at full term, with both extraintestinal pathogenic and neonatal meningitis virulence factors. Clinicians should remain aware of emerging pathotypes and new preventive and therapeutic strategies for E. coli infections in neonates.

Dr. Geslain is a pediatrician in the pediatric intensive care unit at Robert Debré University Hospital in Paris and a PhD student in the infection, antimicrobials, modelling, evolution laboratory at the Université Paris Cité INSERM. His research interests focus on infectious diseases.

Top

References

  1. Leying  H, Suerbaum  S, Kroll  HP, Stahl  D, Opferkuch  W. The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli. Infect Immun. 1990;58:2227. DOIPubMedGoogle Scholar
  2. Mariani-Kurkdjian  P, Lemaître  C, Bidet  P, Perez  D, Boggini  L, Kwon  T, et al. Haemolytic-uraemic syndrome with bacteraemia caused by a new hybrid Escherichia coli pathotype. New Microbes New Infect. 2014;2:12731. DOIPubMedGoogle Scholar
  3. Olesen  B, Jensen  C, Olsen  K, Fussing  V, Gerner-Smidt  P, Scheutz  F. VTEC O117:K1:H7. A new clonal group of E. coli associated with persistent diarrhoea in Danish travellers. Scand J Infect Dis. 2005;37:28894. DOIPubMedGoogle Scholar
  4. Dallman  T, Cross  L, Bishop  C, Perry  N, Olesen  B, Grant  KA, et al. Whole genome sequencing of an unusual serotype of Shiga toxin-producing Escherichia coli. Emerg Infect Dis. 2013;19:13024. DOIPubMedGoogle Scholar
  5. Bidet  P, Birgy  A, Ouldali  N, Béchet  S, Levy  C, Madhi  F, et al. Comparative genomic analysis of ESBL-producing Escherichia coli from faecal carriage and febrile urinary tract infection in children: a prospective multicentre study. JAC Antimicrob Resist. 2022;4:dlac056.
  6. Peigne  C, Bidet  P, Mahjoub-Messai  F, Plainvert  C, Barbe  V, Médigue  C, et al. The plasmid of Escherichia coli strain S88 (O45:K1:H7) that causes neonatal meningitis is closely related to avian pathogenic E. coli plasmids and is associated with high-level bacteremia in a neonatal rat meningitis model. Infect Immun. 2009;77:227284. DOIPubMedGoogle Scholar
  7. Basmaci  R, Bonacorsi  S, Bidet  P, Biran  V, Aujard  Y, Bingen  E, et al. Escherichia coli meningitis features in 325 children from 2001 to 2013 in France. Clin Infect Dis. 2015;61:77986. DOIPubMedGoogle Scholar
  8. Bonacorsi  S, Clermont  O, Houdouin  V, Cordevant  C, Brahimi  N, Marecat  A, et al. Molecular analysis and experimental virulence of French and North American Escherichia coli neonatal meningitis isolates: identification of a new virulent clone. J Infect Dis. 2003;187:1895906. DOIPubMedGoogle Scholar
  9. Zhou  Z, Alikhan  NF, Mohamed  K, Fan  Y, Achtman  M; Agama Study Group. The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res. 2020;30:13852. DOIPubMedGoogle Scholar
  10. Cointe  A, Birgy  A, Bridier-Nahmias  A, Mariani-Kurkdjian  P, Walewski  V, Lévy  C, et al. Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options. J Antimicrob Chemother. 2020;75:53742. DOIPubMedGoogle Scholar

Top

Table

Top

Cite This Article

DOI: 10.3201/eid2908.230169

Original Publication Date: July 11, 2023

Table of Contents – Volume 29, Number 8—August 2023

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Guillaume Geslain, Pediatric Intensive Care Unit, Robert Debré Hospital, AP-HP, 48 Boulevard Sérurier, 75019 Paris, France

Send To

10000 character(s) remaining.

Top

Page created: June 06, 2023
Page updated: July 20, 2023
Page reviewed: July 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external